It is a healthcare private limited company based in Yadadri Bhongir, Telangana, India, established in 2018.
2018 | Yadadri Bhongir, Telangana, India | ActiveRit Qik Homoeo Pharmaceuticals Private Limited, a active private limited company, was established on 27 August 2018 in Yadadri Bhongir, Telangana, India. Engaging in medical equipment retail & distribution within the healthcare sector, it holds CIN: U74999TG2018PTC126291. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Nataraju Chennapai (Director), Kalavathi Chennapai (Director). It holds ₹1.15 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 16-48/A, Rajanagaram Village Kolanupaka, Aler Mandal, Yadadri Bhongir, Telangana, 508101.
U74999TG2018PTC126291
126291
27 August 2018
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Rit Qik Homoeo Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nataraju Chennapai | Director | 27 Aug 2018 | Current |
| Kalavathi Chennapai | Director | 27 Aug 2018 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rit Qik Homoeo Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 19.47% decrease. The company also saw a substantial improvement in profitability, with a 56.48% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.43%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Rit Qik Homoeo Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹11,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 May 2020 | State Bank Of India | ₹1.15 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Rit Qik Homoeo Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rit Qik Homoeo Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rit Qik Homoeo Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Rit Qik Homoeo Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Rit Qik Homoeo Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
Progress on A charge with State Bank Of India amounted to Rs. 11.50 M with Charge ID 100367681 was registered on 20 May 2020. was documented.
Nataraju Chennapai was appointed as a Director was appointed as a Director on 27 Aug 2018 & has been associated with this company since 7 years 3 months . was recorded as a recent event.
Progress on Kalavathi Chennapai was appointed as a Director was appointed as a Director on 27 Aug 2018 & has been associated with this company since 7 years 3 months . was documented.
Progress on Rit Qik Homoeo Pharmaceuticals Private Limited was registered on 27 Aug 2018 with Roc Hyderabad & aged 7 years 3 months as per MCA records. was documented.
The CIN of Rit Qik Homoeo Pharmaceuticals Private Limited is U74999TG2018PTC126291.
Rit Qik Homoeo Pharmaceuticals Private Limited is headquartered at 16-48/A, Rajanagaram Village Kolanupaka, Aler Mandal, Yadadri Bhongir, Telangana, 508101.
Rit Qik Homoeo Pharmaceuticals Private Limited was incorporated on 27 August 2018.
The current directors of Rit Qik Homoeo Pharmaceuticals Private Limited are
The primary industry of Rit Qik Homoeo Pharmaceuticals Private Limited is Healthcare.
Rit Qik Homoeo Pharmaceuticals Private Limited is unlisted.
The authorized capital of Rit Qik Homoeo Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX